Discovery of H. pylori T cell epitopes unique to minority populations that could contribute to increased gastric cancer rates.
发现少数群体特有的幽门螺杆菌 T 细胞表位,可能导致胃癌发病率增加。
基本信息
- 批准号:10198572
- 负责人:
- 金额:$ 43.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-05-01 至 2024-04-30
- 项目状态:已结题
- 来源:
- 关键词:AgeAllelesAmerican IndiansAntibiotic ResistanceAntigen PresentationArizonaBacterial InfectionsBindingBiological AssayCD4 Positive T LymphocytesCancer DiagnosticsCancer EtiologyCatalogsCaucasiansCessation of lifeCharacteristicsChronicChronic DiseaseCodeCommunicable DiseasesCommunitiesCoupledDevelopmentDigestionDiseaseDuodenal UlcerEpitopesEthicsEthnic groupExhibitsGastric lymphomaGastric ulcerGastritisGeneticGenetic VariationGenetic studyGenomeGeographic LocationsGoalsHelicobacter InfectionsHelicobacter pyloriHelicobacter pylori induced gastric cancerHispanic AmericansHispanicsHistocompatibility Antigens Class IIHospitalizationHumanHuman GeneticsHuman bodyImmuneImmune systemIn VitroIncidenceIndividualInflammationInvestigationLaboratoriesLeadLibrariesLifeLiquid substanceMajor Histocompatibility ComplexMalignant NeoplasmsMinorityMinority GroupsMorbidity - disease rateMusNative AmericansNavajoPeptidesPlayPopulationPrevalenceProteinsProteomicsPublishingRaceRecordsRiskRoleSocioeconomic StatusStomachStomach DiseasesSurvival RateSynthesis ChemistryT cell responseT-Lymphocyte EpitopesTechnologyTherapeutic InterventionUlcerUnited StatesUniversitiesVariantWorkcancer survivalcarcinogenesisdisorder riskgenetic predictorsgenetic variantgenome sequencinggenomic datahigh risk populationhospitalization ratesin vitro Assaymalignant stomach neoplasmmembermicrobiome componentsmortalitymucosa-associated lymphoid tissue lymphomanovelpathogenwhole genome
项目摘要
Helicobacter pylori (H. pylori) is a bacterial infection which can be eradicated from the human body by most
antibiotics, though, resistance is on the rise. The pathogen seems to play a role in healthy human digestion, as
a component of the microbiome, but is also associated with development of ulcers, stomach cancer and
stomach lymphomas. It is known that H. pylori-induced immune inflammation elevates the risk for gastritis and
gastric cancer. In the United States (US), prevalence varies by geographic location, ethnic background,
socioeconomic status, and age. For example, Navajo Nation members and Hispanics have disproportionately
high rates of stomach cancer compared to Caucasians. While stomach cancer is associated with H. pylori
infection, why certain populations are at increased risk at developing gastric cancer are not completely
understood. Published studies suggest a role for H. pylori variation, human MHC types, and T cell response for
inflammation and gastritis. However, the investigation into H. pylori variation and how human MHC present
different peptides to the immune system have not been investigated at large scale. This proposal seeks to
investigate this infectious-chronic disease interface by examining H. pylori genetic variation among Native
Americans living in Northern Arizona and Hispanics, what peptides can be presented by common Native
American and Hispanic MHC alleles, and how differential antigen presentation could play a role in H. pylori
induced inflammation and gastric cancer development. Our overall goals are to define the H. pylori protein
epitope space that could be commonly presented by Native American and Hispanic MHC alleles in vitro, and to
contrast this with epitopes that are presented by common Caucasians MHC alleles. Our hypothesis is that
there are unique H. pylori peptides presented by common Native American and Hispanic MHC class II alleles
compared to the larger Caucasian population. Specifically, we aim to SA1: Perform whole genome sequencing
of H. pylori strains isolated from Native Americans and generate PepSeq epitope libraries from predicted
coding regions in the new and current genomic data, and SA2: Perform MHC-PepSeq binding studies using
common Native American and Hispanic, as well as, generally common USA MHC class II alleles. We expect to
better understand, through laboratory and synthetic chemistry the association of common MHC class II
antigens within an ethic group and their interaction with H. pylori from high-risk populations. If successful, this
project will have an impact at several levels: First, it will make available to the community a large set of
potential CD4+ T cell epitopes that could assist in H. pylori and H. pylori gastric cancer diagnostics. Second, it
will identify unique epitopes to a minority population that could contribute to increased risk of H. pylori induced
gastric cancer. Therapeutic intervention is possible for those at high disease risk.
幽门螺杆菌(Helicobacter pylori, H. pylori)是一种大多数人都能从人体中根除的细菌感染
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Erik W Settles其他文献
Erik W Settles的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Erik W Settles', 18)}}的其他基金
Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis
早期体内表达的抗原及其在球孢子菌病毒力、免疫反应和疫苗中的作用
- 批准号:
10689682 - 财政年份:2022
- 资助金额:
$ 43.82万 - 项目类别:
Early in vivo expressed antigens and their role in virulence, immune response, and vaccines for coccidioidomycosis
早期体内表达的抗原及其在球孢子菌病毒力、免疫反应和疫苗中的作用
- 批准号:
10356629 - 财政年份:2022
- 资助金额:
$ 43.82万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 43.82万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 43.82万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 43.82万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 43.82万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 43.82万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 43.82万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 43.82万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 43.82万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 43.82万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 43.82万 - 项目类别:














{{item.name}}会员




